These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1790516)

  • 1. Fluoxetine treatment of obsessive-compulsive disorder.
    Solyom L; Solyom C; Ledwidge B
    Can J Psychiatry; 1991 Dec; 36(10):723-7. PubMed ID: 1790516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
    Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL
    Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM
    Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG; Thatte S; Wiggins D
    Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine in the treatment of obsessive compulsive disorder.
    Montgomery SA; Manceaux A
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():5-9. PubMed ID: 1355499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
    Browne M; Horn E; Jones TT
    Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 8. Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis.
    Cox BJ; Swinson RP; Morrison B; Lee PS
    J Behav Ther Exp Psychiatry; 1993 Jun; 24(2):149-53. PubMed ID: 8263222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E; Mullen L; DeCaria CM; Skodol A; Schneier FR; Liebowitz MR; Klein DF
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.
    Ackerman DL; Greenland S; Bystritsky A; Morgenstern H; Katz RJ
    J Clin Psychopharmacol; 1994 Aug; 14(4):247-54. PubMed ID: 7962680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
    Mattes JA
    Am J Psychiatry; 1994 Oct; 151(10):1524. PubMed ID: 8092352
    [No Abstract]   [Full Text] [Related]  

  • 12. Olfactory reference syndrome responds to clomipramine but not fluoxetine: a case report.
    Dominguez RA; Puig A
    J Clin Psychiatry; 1997 Nov; 58(11):497-8. PubMed ID: 9413419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.
    Grady TA; Pigott TA; L'Heureux F; Hill JL; Bernstein SE; Murphy DL
    Am J Psychiatry; 1993 May; 150(5):819-21. PubMed ID: 8480832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Price LH
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine in obsessive compulsive disorder in adolescents.
    Bouvard M; Dugas M
    Int Clin Psychopharmacol; 1993; 8(4):307-10. PubMed ID: 8277152
    [No Abstract]   [Full Text] [Related]  

  • 17. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
    Graae F; Gitow A; Piacentini J; Jaffer M; Liebowitz M
    Am J Psychiatry; 1992 Jan; 149(1):149-50. PubMed ID: 1728180
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoxetine-clomipramine interaction.
    Sternbach H
    J Clin Psychiatry; 1995 Apr; 56(4):171-2. PubMed ID: 7713858
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuing obsessive-compulsive disorder medication with behavior therapy.
    Baer L; Ricciardi J; Keuthen N; Pettit AR; Buttolph ML; Otto M; Minichiello W; Jenike MA
    Am J Psychiatry; 1994 Dec; 151(12):1842. PubMed ID: 7977900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.